EKOS product catheter.

EKOS™ Endovascular System

HI-PEITHO video series

The Results are Clear. Intervene with EKOS

HI-PEITHO Unpacked

In this 5-part video series, we explore the components of HI-PEITHO, the first large-scale global randomized controlled trial (N=544) powered to determine whether ultrasound-facilitated, catheter-directed thrombolysis (USCDT) via the EKOS Endovascular System plus anticoagulation (AC) improves outcomes versus anticoagulation alone in acute intermediate-risk pulmonary embolism (PE).


HI-PEITHO: Overview

Start with a concise overview of the HI-PEITHO Trial and hear leading experts introduce the rationale, clinical questions, and importance of the study.


HI-PEITHO: Trial Design

Watch as Dr. Peter Monteleone explains why the HI-PEITHO Trial was needed and what randomized evidence means for patient care.


HI-PEITHO: Results

Listen to Prof. Stavros Konstantinides explain the clinical rationale, patient selection, and the primary trial results.


HI-PEITHO: EKOS Technology

Dr. Michael Young discusses the technology behind EKOS and what the HI-PEITHO results could mean for the future of PE care.


HI-PEITHO: Putting Evidence into Practice

Watch as Dr. Soophia Naydenov explains risk stratification, the NEWS score, and applying clinical evidence to critical decision making when treating PE patients.

icon of open envelope with letter

Stay up to date

Receive emails on the latest advances, EKOS clinical data and news.

Caution:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.